Medicare Enrolled

Dr. Alexander Glaros, M.D.

Pediatrics · Detroit, MI
Speaking/Promotional
3901 BEAUBIEN ST, Detroit, MI 48201
3137455515
In practice since 2014 (12 years)
NPI: 1114330339 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Glaros from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Glaros? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Glaros

Dr. Alexander Glaros is a pediatrics specialist in Detroit, MI, with 12 years of NPI registration.

Between the years covered by Open Payments, Dr. Glaros received a total of $34,624 from 13 pharmaceutical and/or device companies across 57 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatrics. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Glaros is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice $34,624 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$34,624
Total received (2018-2024)
Avg $5,771/year across 6 years
Top 2% in MI for pediatrics
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
13
Companies
57
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21,054 (60.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$12,460 (36.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,110 (3.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$18,723
2023
$7,006
2022
$5,485
2021
$3,187
2019
$206
2018
$18

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Agios Pharmaceuticals, Inc.
$14,550
PFIZER INC.
$2,934
bluebird bio, Inc.
$1,240
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Agios Pharmaceuticals, Inc.
$15,646
PFIZER INC.
$9,437
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$4,412
Global Blood Therapeutics, Inc.
$3,348
bluebird bio, Inc.
$1,240
Novartis Pharmaceuticals Corporation
$120
Chiesi USA, Inc.
$118
Silvergate Pharmaceuticals, Inc.
$107
Emmaus Medical, Inc.
$104
Takeda Pharmaceuticals U.S.A., Inc.
$32
Vertex Pharmaceuticals Incorporated
$25
Genentech USA, Inc.
$18
Alexion Pharmaceuticals, Inc.
$17
Top 3 companies account for 85.2% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · CUVITRU · Endari · FERRIPROX · HEMLIBRA · LYFGENIA · OXBRYTA · PYRUKYND · ULTOMIRIS · XIFAXAN · Xatmep
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (61%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pediatrics and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for pediatrics in MI.

Looking for a pediatrics specialist in Detroit?
Compare pediatricians in the Detroit area by procedure volume, costs, and industry payment transparency.
Browse pediatricians nearby

Geographic Context

Pediatricians within 10 mi
949
Per 100K population
53.5
County median income
$59,521
Nearest hospital
HARPER UNIVERSITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Glaros is a pediatrics specialist, with speaking/promotional industry engagement in the top 2% of MI peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Glaros receive payments from pharmaceutical companies?
Yes. Dr. Glaros received a total of $34,624 from 13 companies across 57 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Glaros) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →